The exposome - Exciting opportunities for discoveries in reproductive and perinatal epidemiology

Paediatric and Perinatal Epidemiology

Volumn 27, Issue 3, 2013, Pages 229-236

  Buck Louis, Germaine M ^a   Yeung, Edwina ^b   Sundaram, Rajeshwari ^a   Laughon, S Katherine ^b   Zhang, Cuilin ^b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

environment; exposome; exposure; fecundity; fertility; sensitive windows

Indexed keywords

ADVERSE OUTCOME; ARTICLE; CHILD DEVELOPMENT; CONCEPTUAL FRAMEWORK; ENVIRONMENTAL EXPOSURE; FERTILITY; HUMAN; METHODOLOGY; PERINATAL PERIOD; REPRODUCTION;

ENVIRONMENT; FEMALE; FERTILITY; HUMANS; MALE; REPRODUCTION; REPRODUCTIVE TECHNIQUES, ASSISTED; TIME FACTORS;

EID: 84876144082     PISSN: 02695022     EISSN: 13653016     Source Type: Journal    
DOI: 10.1111/ppe.12040     Document Type: Article

References (48)

1. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proceedings of the National Academy of Sciences of the United States of America 2009; 41: 9362-9367. DOI: 10.1073/pnas.0903103106.
2. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, et al. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. The New England Journal of Medicine 2000; 343: 78-85.
3. Willett WC,. Balancing life-style and genomics research for disease prevention. Science 2002; 296: 695-698.
4. Wild C,. Complementing the genome with an 'exposome': the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiology, Biomarkers & Prevention 2005; 14: 1847-1850.
5. Rappaport SM, Smith MT,. Environment and disease risks. Science 2010; 330: 460-461. DOI: 10.1126/science.1192603.
6. Wild CP,. The exposome: from concept to utility. International Journal of Epidemiology 2012; 41: 24-32.
7. Buck Louis GM, Sundaram R,. Exposome: time for transformative research: invited commentary. Statistics in Medicine 2012; 31: 2569-2575. DOI: 10.10021SIM.5496.
8. Peters A, Hoek G, Katsouyanni K,. Understanding the link between environmental exposures and health: does the exposome promise too much? Journal of Epidemiology and Community Health 2012; 66: 103-105. DOI: 10.1136/jech-2011-200643.
9. Patel CJ, Bhattacharya J, Butte AJ,. An environment-wide association study (EWAS) on type 2 diabetes mellitus. PLoS ONE 2010; 5: e10746. DOI: 10.1371/journal.pone.0010746.
10. Patel CJ, Cullen MR, Ioannidis JPA, Butte AJ,. Systematic evaluation of environmental factors: persistent pollutants and nutrients correlated with serum lipid levels. International Journal of Epidemiology 2012; 41: 828-843. DOI: 10.1093/ije/dys003.
11. Skakkebaek NE, Rajpert-De Meyts E, Main KM,. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Human Reproduction 2001; 16: 972-978.
12. Moller H,. Trends in sex-ratio, testicular cancer and male reproductive hazards: are they connected? APMIS 1998; 106: 232-238.
13. Buck Louis GM, Cooney MA, Peterson CM,. The ovarian dysgenesis syndrome. Journal of Developmental Origins of Health and Disease 2011; 2: 25-35.
14. Boomsma CM, Eijkemans MJ, Hughes EG, Visser GH, Fauser BC, Macklon NS,. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Human Reproduction Update 2006; 12: 673-683.
15. Fauser BCJM, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, et al. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertility and Sterility 2012; 97: e1-25.
16. Gluck PD, Hanson MA,. Living with the past: evolution, development, and patterns of disease. Science 2004; 305: 1733-1736.
17. Gray LE Jr, Ostby J, Furr J, Price M, Veeramachaneni DN, Parks L,. Perinatal exposure to the phthalates DEHP, BBP, and DINP, but not DEP, DMP, or DOTP, alters sexual differentiation of the male rat. Toxicological Sciences 2000; 58: 350-365.
18. Abbott DH, Dumesic DA, Franks S,. Developmental origin of polycystic ovary syndrome-a hypothesis. Journal of Endocrinology 2002; 174: 1-5.
19. Eisner JR, Barnett MA, Dumesic DA, Abbott DH,. Ovarian hyperandrogenism in adult female rhesus monkeys exposed to prenatal androgen excess. Fertility and Sterility 2002; 77: 167-172.
20. Lawson C, Gieske M, Murdoch B, Ye P, Li Y, Hassold T, et al. Gene expression in the fetal mouse ovary is altered by exposure to low doses of bisphenol A. Biology of Reproduction 2011; 84: 79-86.
21. Wolstenholme JT, Edwards M, Shetty SR, Gatewood JD, Taylor JA, Rissman EF, et al. Gestational exposure to bisphenol A produces transgenerational changes in behaviors and gene expression. Endocrinology 2012; 153: 3828-3838. DOI: 10.1210/en.2012-1195.
22. Brouwers MM, Feitz WF, Roelofs LA, Kiemeney LA, de, Gier RP, Roeleveld N,. Hypospadias: a transgenerational effect of diethylstilbestrol? Human Reproduction 2006; 21: 666-669.
23. Newbold RR, Padilla-Banks E, Jefferson WN,. Adverse effects of the model environmental estrogen diethylstilbestrol are transmitted to subsequent generations. Endocrinology 2006; 147 (6 Suppl.): S11-S17.
24. Brown S,. From genomics. to metabolomics. New technologies in embryo physiology. Focus on Reproduction 2009; January: 22-29.
25. Dumoulin JC, Land JA, Van Montfoort AP, Nelissen EC, Coonen E, Derhaag JG, et al. effect of in vitro culture of human embryos on birthweight of newborns. Human Reproduction 2010; 25: 605-612.
26. Eaton JL, Lieberman ES, Stearns C, Chinchilla M, Racowsky C,. Embryo culture media and neonatal birthweight following IVF. Human Reproduction 2012; 27: 375-379.
27. Takatori S, Akutsu K, Kondo F, Ishii R, Nakazawa H, Makino T,. Di(2-ethylhexyl)phthalate and mono(2-ethylhexyl)phthalate in media for in vitro fertilization. Chemosphere 2012; 86: 454-459.
28. Iwasaki Y, Terayama E, Kato A, Ito R, Saito K, Makino T, et al. Quantitative analysis of perfluorinated chemicals in media for in vitro fertilization and related samples. Chemosphere 2012; 88: 445-449.
29. Chason RJ, Csokmay J, Segars JH, DeCherney AH, Armant DR,. Environment and epigenetic effects upon preimplantation embryo metabolism and development. Trends in Endocrinology and Metabolism 2011; 22: 412-420.
30. Buck Louis GM,. Fecundity and fertility. In: Reproductive and Perinatal Epidemiology. Editors:, Buck Louis GM, Platt RW,. New York: Oxford University Press, 2011; pp. 16-61.
31. Jensen MS, Wilcox AJ, Olsen J, Bonde JP, Thulstrup AM, Ramlau-Hansen CH, et al. Cryptorchidism and hypospadias in a cohort of 934,538 Danish boys: the role of birth weight, gestational age, body dimensions, and fetal growth. American Journal of Epidemiology 2012; 175: 917-925.
32. Raman JD, Nobert CF, Goldstein M,. Increased incidence of testicular cancer in men presenting with infertility and abnormal semen analysis. Journal of Urology 2005; 174: 1819-1822.
33. Asklund C, Jorgensen N, Skakkebaek NE, Jensen TK,. Increased frequency of reproductive health problems among fathers of boys with hypospadias. Human Reproduction 2007; 22: 2639-2646.
34. Jensen TK, Jacobsen R, Christensen K, Nielsen NC, Bostofte E,. Good semen quality and life expectancy: a cohort study of 43,277 men. American Journal of Epidemiology 2009; 170: 559-565.
35. Wohlfahrt-Veje C, Main KM, Skakkebaek NE,. Testicular dysgenesis syndrome: foetal origin of adult reproductive problems. Clinical Endocrinology 2009; 71: 459-465.
36. Virro MR, Larson-Cook KL, Evenson DP,. Sperm chromatin structure assay (SCSA) parameters are related to fertilization, blastocyst development, and ongoing pregnancy in in vitro fertilization and intracytoplasmic sperm injection cycles. Fertility and Sterility 2004; 81: 1289-1295.
37. Ibáñez L, Potau N, Enríquez G, de, Zegher F,. Reduced uterine and ovarian size in adolescent girls born small for gestational age. Pediatric Research 2000; 47: 575-577.
38. Ibáñez L, Potau N, de, Zegher F,. Ovarian hyporesponsiveness to follicle stimulating hormone in adolescent girls born small for gestational age. Journal of Clinical Endocrinology and Metabolism 2000; 85: 2624-2626.
39. Ibáñez L, Potau N, Ferrer A, Rodriguez-Hierro F, Marcos MV, de, Zegher F,. Reduced ovulation rate in adolescent girls born small for gestational age. Journal of Clinical Endocrinology and Metabolism 2002; 87: 3391-3393.
40. Hediger ML, Hartnett JH, Louis GM,. Association of endometriosis with body size and figure. Fertility and Sterility 2005; 84: 1366-1374.
41. Nina Sinaii N, Cleary SD, Ballweg ML, Nieman LK, Stratton P,. High rates of autoimmune and endocrine disorders, fibromyalgia, chronic fatigue syndrome and atopic diseases among women with endometriosis: a survey analysis. Human Reproduction 2002; 17: 2715-2724.
42. Brinton LA, Gridley G, Persson I, Baron J, Bergqvist A,. Cancer risk after a hospital discharge diagnosis of endometriosis. American Journal of Obstetrics and Gynecology 1997; 176: 572-579.
43. Brinton LA, Sakoda LC, Sherman ME, Frederiksen K, Kjaer SK, Graubard BI, et al. Relationship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors. Cancer Epidemiology, Biomarkers & Prevention 2005; 14: 2929-2935.
44. Rappaport SM,. Biomarkers intersect with the exposome. Biomarkers 2012; 17: 483-489.
45. Buck Louis GM, Lynch CD, Stanford JB, Sweeney AM, Schieve LA, Rockett JC, et al. Prospective pregnancy study designs for assessing reproductive and developmental toxicants. Environmental Health Perspectives 2004; 112: 79-86.
46. Golding J, Birmingham K, Jones R, (eds). A guide to undertaking a birth cohort study: purposes, pitfalls and practicalities. Paediatric and Perinatal Epidemiology 2009; 23 (Suppl. 1): 1-229.
47. Niswander KR, Gordon M,. The Women and Their Pregnancies. Philadelphia, PA: W.B. Saunders, 1972.
48. Koren O, Goodrich JK, Cullender TC, Spor A, Laitinen K, Kling Backhed H, et al. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell 2012; 150: 470-480.